English 
Japanese 
Experimental Animals, 65(3), 285-292 (2016)
Hai-Ying, Chi; Nagano, Kiori; Ezzikouri, Sayeh; Yamaguchi, Chiho; Kayesh, Mohammad Enamul Hoque; Rebbani, Khadija; Kitab, Bouchra; Nakano, Hirohumi; Kouji, Hiroyuki; Kohara, Michinori; Tsukiyama-Kohara, Kyoko
Archives: News
Follow-up: Prospective compound design using the ‘SAR Matrix’ method and matrix-derived conditional probabilities of activity
F1000Research, 4, 75 (2015)
Gupta-Ostermann, Disha; Hirose, Yoichiro; Odagami, Takenao; Kouji, Hiroyuki; Bajorath, Jurgen
Three-dimensional structural diversity-oriented peptidomimetics based on the cyclopropylic strain
Organic Letters, 15(7), 1686-1689 (2013)
Mizuno, Akira; Miura, Shiho; Watanabe, Mizuki; Ito, Yoshihiko; Yamada, Shizuo; Odagami, Takenao; Kogami, Yuji; Arisawa, Mitsuhiro; Shuto, Satoshi
Protein-Protein Interaction をターゲットとした創薬
Medchem News, 22(1), 21-24 (2012) (Japanese)
Odagami, Takenao; Kouji, Hiroyuki
Deprotection of Nin-formyl group on tryptophan by application of new reagent, 1,2-dimethylethylendiamine in aqueous solution
Advances in Experimental Medicine and Biology, 611, 159-160 (2009)
Odagami, Takenao; Kogami, Yuji; Kouji, Hiroyuki; Tsuda, Yuko; Okada, Yoshio
Identification of new agonists of urotensin-II from a cyclic peptide library
Bioorganic and Medicinal Chemistry, 17, 6742-6747 (2009)
Odagami, Takenao; Tsuda, Yuko; Kogami, Yuji; Kouji, Hiroyuki; Okada, Yoshio
Deprotection of the indole (Nind)-formyl (For) group on tryptophan employing a new reagent, N,N’-dimethylethylendiamine (DMEDA) in an aqueous solution
Chemical and Pharmaceutical Bulletin, 57(2), 211-213 (2009)
Odagami, Takenao; Tsuda, Yuk; Kogami, Yuji; Kouji, Hiroyuki; Okada, Yoshio
Servier and PRISM BioLab enter drug discovery collaboration for a novel target
PRISM BioLab provides PepMetics® (peptide mimetic small molecules) Technology for generating Hit and Lead compounds against Servier’s novel target. Read Full Press Release
PRISM Biolab and Merck enter multi-project drug discovery collaboration
PRISM Biolab provides The PRISM Library, proprietary library of peptide mimetic small molecules for screening against Merck’s novel targets Read Full Press Release
PRISM Biolab and Boehringer Ingelheim enter multi-project drug discovery collaboration
PRISM Biolab provides The PRISM Library, proprietary library of peptide mimetic small molecules for screening against Boehringer Ingelheim’s novel targets Read Full Press Release